Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,5842 USD | +6,86% | +2,31% | -44,89% |
Omzet 2024 * | 1,63 mln. 1,52 mln. | Omzet 2025 * | 13,61 mln. 12,73 mln. | Marktkapitalisatie | 4,43 mln. 4,14 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -16 mln. -14,96 mln. | Nettowinst (verlies) 2025 * | -11 mln. -10,29 mln. | EV/omzet 2024 * | 2,72 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,33 x |
K/w-verhouding 2024 * |
-0,19
x | K/w-verhouding 2025 * |
-0,25
x | Werknemers | 7 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,45% |
Recentste transcriptie over Ensysce Biosciences, Inc.
1 dag | +6,86% | ||
1 week | +2,31% | ||
Lopende maand | -26,07% | ||
1 maand | -26,98% | ||
3 maanden | -62,79% | ||
6 maanden | -42,73% | ||
Lopend jaar | -44,89% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 01-01-09 |
David Humphrey
DFI | Director of Finance/CFO | 55 | 01-02-21 |
Jeffrey Millard
COO | Chief Operating Officer | 49 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Martin
BRD | Director/Board Member | 63 | 01-01-20 |
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 01-01-09 |
Bob Gower
CHM | Chairman | 86 | 01-01-08 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,5842 | +6,86% | 176 560 |
25-04-24 | 0,5467 | -2,13% | 59 748 |
24-04-24 | 0,5586 | +0,05% | 42 999 |
23-04-24 | 0,5583 | +3,20% | 43 903 |
22-04-24 | 0,541 | -5,25% | 53 698 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,89% | 4,43 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |